Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin.
about
A randomized, double-blind, placebo-controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy.Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapyStatistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals.Early and Late Onset Side Effects of Photodynamic Therapy.
P2860
Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prostaglandin E2 and nitric ox ...... dynamic therapy in human skin.
@en
Prostaglandin E2 and nitric oxide mediate the acute inflammatory
@nl
type
label
Prostaglandin E2 and nitric ox ...... dynamic therapy in human skin.
@en
Prostaglandin E2 and nitric oxide mediate the acute inflammatory
@nl
prefLabel
Prostaglandin E2 and nitric ox ...... dynamic therapy in human skin.
@en
Prostaglandin E2 and nitric oxide mediate the acute inflammatory
@nl
P2093
P2860
P356
P1476
Prostaglandin E2 and nitric ox ...... odynamic therapy in human skin
@en
P2093
G F Clough
P S Friedmann
R C C Brooke
P2860
P304
P356
10.1111/BJD.12562
P407
P577
2013-09-01T00:00:00Z